Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Leishmaniasis impact and treatment access.
den Boer M, Argaw D, Jannin J, Alvar J. den Boer M, et al. Among authors: alvar j. Clin Microbiol Infect. 2011 Oct;17(10):1471-7. doi: 10.1111/j.1469-0691.2011.03635.x. Clin Microbiol Infect. 2011. PMID: 21933305 Review.
Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
Laguna F, Adrados M, Alvar J, Soriano V, Valencia ME, Moreno V, Polo R, Verdejo J, Jiménez MI, Martínez P, Martínez ML, González-Lahoz JM. Laguna F, et al. Among authors: alvar j. Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):898-903. doi: 10.1007/BF01700556. Eur J Clin Microbiol Infect Dis. 1997. PMID: 9495670
Developments in the treatment of visceral leishmaniasis.
den Boer ML, Alvar J, Davidson RN, Ritmeijer K, Balasegaram M. den Boer ML, et al. Among authors: alvar j. Expert Opin Emerg Drugs. 2009 Sep;14(3):395-410. doi: 10.1517/14728210903153862. Expert Opin Emerg Drugs. 2009. PMID: 19708817 Review.
Combination therapy for visceral leishmaniasis.
van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. van Griensven J, et al. Among authors: alvar j. Lancet Infect Dis. 2010 Mar;10(3):184-94. doi: 10.1016/S1473-3099(10)70011-6. Lancet Infect Dis. 2010. PMID: 20185097 Review.
152 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page